Global Rapid Point-of-Care (PoC) Diagnostics Market Size By Type (Instrument Systems, Tests Software And Services), By Application (Clinics, Hospitals), By Region, And Segment Forecasts, 2023 to 2032

The Global Rapid Point-of-Care (PoC) Diagnostics Market was valued at USD 27.4 billion in 2023 and is projected to reach USD 52.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2023–2031. The rapid PoC diagnostics market is gaining significant traction due to the growing demand for quick and accurate diagnostic results, increasing prevalence of chronic and infectious diseases, and advancements in diagnostic technology. These devices offer decentralized testing, enabling early diagnosis and timely treatment, which is especially crucial in resource-limited settings and emergency care.

Drivers:

1. Rising Demand for Quick Diagnosis:

With the growing incidence of diseases such as diabetes, cardiovascular ailments, and infectious conditions, healthcare providers are increasingly adopting PoC diagnostics to reduce time to treatment and improve outcomes.

2. Technological Advancements in Portable Testing Devices:

The integration of miniaturized biosensors, mobile connectivity, and AI-driven analytics has significantly enhanced the reliability and efficiency of PoC diagnostic devices.

3. Increasing Adoption in Homecare and Remote Settings:

The shift towards home-based care and telehealth services has created a strong demand for portable diagnostic tools that deliver immediate results without the need for centralized lab testing.

Restraints:

1. Regulatory Challenges and Approval Delays:

Obtaining regulatory approval for PoC devices can be complex and time-consuming due to stringent standards, particularly for new technology platforms.

2. Cost Sensitivity in Low-Income Regions:

While PoC diagnostics are cost-effective long-term, the upfront costs of devices and consumables may restrict adoption in cost-sensitive healthcare systems.

Opportunity:

1. Expansion of Diagnostic Networks in Emerging Economies:

Emerging markets, particularly in Asia-Pacific and Latin America, are witnessing increasing investments in healthcare infrastructure, paving the way for wider adoption of PoC diagnostics.

2. Integration with Digital Health and AI:

The combination of PoC diagnostics with digital health platforms and AI analytics is expected to revolutionize remote patient monitoring and personalized medicine.

Market by System Type Insights:

In 2023, the Lateral Flow Assays (LFA) segment held the largest market share due to its ease of use, low cost, and widespread application in infectious disease detection and pregnancy testing. However, the Molecular Diagnostics segment is projected to witness the fastest growth, driven by its superior sensitivity and specificity in detecting conditions like COVID-19, HIV, and influenza.

Market by End-use Insights:

The Hospital & Clinics segment led the market in 2023, benefiting from the need for immediate diagnostic decisions in emergency and inpatient settings. Meanwhile, the Homecare segment is rapidly growing as chronic disease management and remote patient monitoring become more prevalent.

Market by Regional Insights:

North America dominated the global PoC diagnostics market in 2023 due to its advanced healthcare infrastructure, high adoption of innovative diagnostic technologies, and favorable reimbursement frameworks. The Asia-Pacific region is expected to register the fastest CAGR during the forecast period, supported by government initiatives to improve healthcare access and growing awareness of preventive healthcare.

Competitive Scenario:

Key players in the Global Rapid Point-of-Care Diagnostics Market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Becton, Dickinson and Company, QuidelOrtho Corporation, bioMérieux, Chembio Diagnostics, Sekisui Diagnostics, and Trinity Biotech. These companies are investing in R&D, expanding product portfolios, and forming strategic partnerships to strengthen their market presence.

Recent developments include:

2023: Abbott Laboratories launched a next-generation PoC COVID-19 and flu test using multiplex molecular diagnostics.

2024: Roche Diagnostics introduced a connected PoC testing platform designed to streamline diagnostics across primary care clinics.

2025: Danaher Corporation acquired a biotech startup specializing in AI-powered diagnostic algorithms to enhance its PoC offering.

Scope of Work – Global Rapid Point-of-Care (PoC) Diagnostics Market

Report Metric Details

Market Size (2023) USD 27.4 billion

Projected Market Size (2031) USD 52.1 billion

CAGR (2023–2031) 8.4%

Market Segments By System Type (Lateral Flow Assays, Molecular Diagnostics, Others), By End-use (Hospitals & Clinics, Homecare, Laboratories, Others)

Growth Drivers Increasing demand for rapid diagnostics, growing disease burden, technological advancements

Opportunities Expansion in emerging markets, integration with AI and digital health platforms

Key Market Developments:

March 2023: QuidelOrtho launched a handheld rapid testing device with digital reporting capabilities aimed at community health centers.

August 2024: bioMérieux entered a partnership with a telemedicine provider to integrate PoC diagnostics in virtual consultations.

January 2025: Siemens Healthineers expanded its Point-of-Care Academy program to train healthcare workers in rural areas on advanced PoC technologies.

FAQs:

1. What is the current market size of the Global Rapid Point-of-Care (PoC) Diagnostics Market?

The market